Follows people with hepatitis B and fatty liver disease over time
Studies how fatty liver disease affects people already living with chronic hepatitis B.
Plain-language title generated from the registry record
Registry title: A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.
Key facts
- Where
- Wuhan, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with chronic hepatitis B. It follows them to see how fatty liver affects the hepatitis B.
- Age
- Over 18 years (minimum age 18 Years)
- Sex
- All sexes can join.
- Disease stage
- Chronic hepatitis B.
- Earlier treatment
- People taking medicines known to cause fatty liver (corticosteroids, methotrexate, tamoxifen) cannot join.
Main reasons for not taking part
- Chronic hepatitis C or D, or HIV co-infection
- Excessive alcohol intake (30 g/d or more for men, 20 g/d or more for women)
- Other chronic liver diseases (e.g. primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, Wilson's disease)
- Taking corticosteroids, methotrexate or tamoxifen
- Pregnancy
Read by machine on 12 November 2026.
Where in China
- Department and Institute of Infectious DiseaseWuhan, ChinaContact: Qin Ning, professorTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Qin Ning
- Trial code
- NCT05255978
- Record updated
- 25 February 2022
- Original description
This is a prospective/retrospective, observational follow-up study of effects of fatty liver on chronic hepatitis B. Patients will join this study who undergo transient elastography with liver stiffness (LS) and CAP measurements or Ultrasonic examination. All recruited subjects will undergo comprehensive clinical, anthropometric and laboratory assessments at the time when transient elastography or Ultrasonic examination is performed. We plan to compare the relationship between chronic hepatitis B and non-alcoholic fatty liver disease. Patients will be divided into several groups based on the demand.Read full original descriptionShow less
A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.
This is a prospective/retrospective, observational follow-up study of effects of fatty liver on chronic hepatitis B. Patients will join this study who undergo transient elastography with liver stiffness (LS) and CAP measurements or Ultrasonic examination. All recruited subjects will undergo comprehensive clinical, anthropometric and laboratory assessments at the time when transient elastography or Ultrasonic examination is performed. We plan to compare the relationship between chronic hepatitis B and non-alcoholic fatty liver disease. Patients will be divided into several groups based on the demand.
Exclusion: -.